ArticleBMC cancer2019
TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model.
Louie Semaan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled ittrialcites it
ArticleBMC cancer2019
Louie Semaan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.